News and Blog

Making Genomics the Standard of Care in Community Cancer Centers

PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer

PierianDx partners with the Belgian Society of Medical Oncology (BSMO) to evaluate potential of comprehensive genomic profiling in late-stage cancer real-world setting across Belgium

PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets

PierianDx Announces the Appointment of Mark McDonough as CEO

PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

Enabling High-Throughput Comprehensive Genomic Profiling

Enabling Targeted Sequencing with Minimal Complexity

Voices of Leaders Interview with Rakesh Nagarajan

Enabling Liquid Biopsy with Minimal Complexity

PierianDx and University Hospital of Augsburg Announce Strategic Partnership

Cancer in the Time of Coronavirus

The Personalized Diagnostics Podcast

Intermountain Healthcare Selects PierianDx Clinical Genomics Solution

PierianDx Closes Series B Financing Round

Visit PierianDx at ACMG 2019

Addressing Common Barriers to Clinical NGS Testing

Why Are Other Healthcare Institutions Bringing Clinical NGS Testing In-House?

The Hurdles of Making Clinical Sequencing a Reality

PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

We Know Precision Medicine: Bryce Daines

AMP 2018

We Know Precision Medicine: Lisa Owen

Better Integrating Pathology into Cancer Care

CAP Distributive Model of NGS Testing

We Know Precision Medicine: Shalini Verma, Laboratory and Medical Director

A Guide for the Interpretation and Reporting of Sequence Variants in Cancer

We Know Precision Medicine: Andy Bredemeyer, VP Product

Less Variation, More Standardization in Somatic Variant Interpretation and Reporting

We Know Precision Medicine: Rakesh Nagarajan

PierianDx Expands to Australia with Addition of Anatomical Pathology PathWest Laboratory Medicine

2bPrecise and PierianDx Collaborate to Deliver a Comprehensive Precision Medicine Solution

PierianDx Hires Healthcare IT, Analytics Pioneer as CEO

PierianDx Partners with ScienceVision to Bring Robust Precision Medicine Support to Southeast Asia

University of Alabama takes a Dogged Approach to Precision Medicine

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

Optimizing the Bioinformatics Output of your Molecular Pathology Lab

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

Cardiology Field Whole-heartedly Ready for Precision Medicine

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

Inova Launches Predictive Phenotyping Study with NIH

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity

PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR

PierianDx Showcases Germline Features in CGW at ACMG 2018

CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients

Precision Medicine in Canada

PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada

Saving Infants with Genetic Testing

PierianDx Customer Dartmouth-Hitchcock Medical Center Illustrates ALK-Rearranged Lung Cancer Patient Case in CAP Today Article

Precision Medicine to Improve Patient Safety

HIMSS18 Round-up: Why the Time for Precision Medicine is Now

PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx Exhibiting at Health Systems Summit

PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

PharmaTech Outlook Spotlights PierianDx in December Issue

PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine

PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170

PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs

Moffitt Cancer Center Showcases its Blueprint for Building a Best-in-Class Precision Medicine Program at PierianDx-hosted Webinar

PierianDx Announces Launch of Clinical Interpretation Services at ACMG 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point

PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW)

University of Vermont Touts the Importance of Clinical Integration to Accelerate Precision Medicine in PierianDx Webinar Series

Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

PierianDx Acquires Tute Genomics

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering

MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data

Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

PierianDx Launches NGS Gateway Program

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

Journal of Molecular Diagnostics

Clinical NGS WUSTL